Literature DB >> 3549396

Preparation and use of calcium phosphate adsorbed vaccines.

E H Relyveld.   

Abstract

Simple or combined D,T,P and inactivated polio vaccines adsorbed onto calcium phosphate are prepared according to two procedures. Antigens can be dialysed in a sodium phosphate solution and quickly mixed with an equal volume of an equimolar solution of calcium chloride, the pH is adjusted to 6.8-7. Toxoids added to the phosphate solution are in this way entrapped within the 3-dimensional network during the formation of the precipitate. Antigens can also be added to a calcium phosphate gel suspension prepared in advance. Results of animal experiments and of field trials using either combined vaccines or simultaneous immunization with diphtheria, tetanus, pertussis, meningococcal and several viral vaccines: polio, rabies, hepatitis-B, etc., will be presented. Several programs have been studied in developing countries, mainly with the aim at simplifying vaccination campaigns. The efficiency of a two-dose regimen with DT vaccine has been ascertained, this has also been applied to pregnant women. Adsorbed tetanus toxoid was successfully used as a diluent for freeze-dried measles, meningococcal polysaccharide and rabies vaccines. Levels of circulating antibodies and potency of vaccines have been measured by new in vivo and in vitro methods. The choice of detoxified purified toxins is desirable for the preparation of vaccines in order to prevent the occurrence of adverse reactions. Local and generalized reactions have been studied. Adverse Arthus-type reactions have been encountered and related with the presence of high levels of circulating tetanus antibodies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3549396

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  9 in total

1.  Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.

Authors:  Tülin Morçӧl; Brett L Hurst; E Bart Tarbet
Journal:  Vaccine       Date:  2017-07-14       Impact factor: 3.641

2.  Biomineralization and size control of stable calcium phosphate core-protein shell nanoparticles: potential for vaccine applications.

Authors:  David Chiu; Weibin Zhou; Sathana Kitayaporn; Daniel T Schwartz; Kaja Murali-Krishna; Terrance J Kavanagh; François Baneyx
Journal:  Bioconjug Chem       Date:  2012-02-10       Impact factor: 4.774

3.  Calcium phosphate nanoparticle adjuvant.

Authors:  Q He; A R Mitchell; S L Johnson; C Wagner-Bartak; T Morcol; S J Bell
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

4.  Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2.

Authors:  Qing He; Alaina Mitchell; Tulin Morcol; Steve J D Bell
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 5.  Adjuvants and inactivated polio vaccine: a systematic review.

Authors:  Jennifer Hawken; Stephanie B Troy
Journal:  Vaccine       Date:  2012-10-03       Impact factor: 3.641

6.  Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.

Authors:  S M Sivakumar; Mohammed M Safhi; M Kannadasan; N Sukumaran
Journal:  Saudi Pharm J       Date:  2011-06-25       Impact factor: 4.330

7.  Reduction of T-Helper Cell Responses to Recall Antigen Mediated by Codelivery with Peptidoglycan via the Intestinal Nanomineral-Antigen Pathway.

Authors:  Rachel E Hewitt; Jack Robertson; Carolin T Haas; Laetitia C Pele; Jonathan J Powell
Journal:  Front Immunol       Date:  2017-03-17       Impact factor: 7.561

8.  A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma.

Authors:  Masato Abei; Toshiyuki Okumura; Kuniaki Fukuda; Takayuki Hashimoto; Masahiro Araki; Kazunori Ishige; Ichinosuke Hyodo; Ayae Kanemoto; Haruko Numajiri; Masashi Mizumoto; Takeji Sakae; Hideyuki Sakurai; Junko Zenkoh; Gerelchuluun Ariungerel; Yu Sogo; Atsuo Ito; Tadao Ohno; Koji Tsuboi
Journal:  Radiat Oncol       Date:  2013-10-16       Impact factor: 3.481

9.  Uptake, recognition and responses to peptidoglycan in the mammalian host.

Authors:  Paulo A D Bastos; Richard Wheeler; Ivo G Boneca
Journal:  FEMS Microbiol Rev       Date:  2021-01-08       Impact factor: 16.408

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.